Meningitis: Symptoms, Vaccine, Prevention, and Contagion

What is Meningitis?

Meningitis is an inflammation of the meninges, which are the three protective membrane layers that envelop the brain and spinal cord: the dura mater, arachnoid mater, and pia mater. It is most commonly caused by bacterial or viral infections, though it can also result from fungal organisms, certain medications, or systemic inflammatory diseases.

Common Symptoms at a Glance

The most characteristic symptoms of meningitis, which may appear suddenly or gradually, in full or only partially, and in any order, include:

• High fever
• General feeling of illness and malaise
• Severe headache
• Stiff neck (neck rigidity)
• Sensitivity to light (photophobia)
• Profound drowsiness and lethargy
• Seizures (convulsions)

Symptoms can develop rapidly within a few hours or more gradually over several days. This slower progression often makes timely diagnosis more challenging.

Who Is at Risk?

Meningitis can affect anyone, at any age. However, because it can spread easily among people living in close contact in confined environments, the groups most frequently at risk include:

• Infants and young children
• Adolescents and university students (dormitory and communal living settings)
• Immunocompromised individuals
• Elderly people

Bacterial vs. Viral Meningitis: Key Differences

Overview of Main Causative Organisms

Key point regarding meningococcal vaccines: Three types are available:

• MenC conjugate vaccine: Protects against serogroup C
• Quadrivalent conjugate vaccine (MenACWY): Protects against serogroups A, C, W, and Y
• MenB vaccine: Protects specifically against serogroup B, the most common cause of meningococcal disease in infants under one year of age

With timely prevention and diagnosis, meningitis can be treated effectively. It is therefore essential to stay up to date with recommended vaccinations and to be familiar with the warning signs of meningitis.

---

Causes

In the vast majority of cases, meningitis results from an infection, typically viral, bacterial, or, less often, fungal.

Many of the bacteria and viruses responsible for meningitis are relatively common microorganisms typically associated with other widespread illnesses. These pathogens can reach the meninges in several ways. They may travel through the bloodstream from initial infection sites in the skin, urinary tract, digestive system, or respiratory tract. From there, they can spread via the cerebrospinal fluid, or CSF, which circulates around the brain and spinal cord.

In some cases of bacterial meningitis, bacteria reach the meninges directly due to severe head trauma or a localized infection near the skull. This can occur, for instance, with a middle ear infection (otitis media) or a sinus infection (sinusitis).

Bacterial Causes by Age Group

Haemophilus influenzae type b (Hib) was once a leading cause of bacterial meningitis in children but has become rare in countries with widespread Hib vaccination programs.

Viral Causes

Viral meningitis can be caused by numerous viruses, including:

• Enteroviruses: The most common cause of viral meningitis; includes coxsackieviruses, echoviruses, and polioviruses.
• Herpesviruses: Including herpes simplex virus (HSV), varicella-zoster virus, Epstein-Barr virus, and cytomegalovirus.
• Mumps virus
• HIV

Nosocomial (Hospital-Acquired) Meningitis

Cases of meningitis acquired during hospital admissions for unrelated conditions are typically caused by gram-negative bacterial strains (source) and present unique diagnostic and therapeutic challenges.

Non-Infectious Meningitis

Non-infectious forms of meningitis are rare and are typically secondary to systemic inflammatory diseases (such as lupus or sarcoidosis) or adverse drug reactions.

---

Symptoms

Recognizing the Disease

Three symptoms form the classic triad of meningitis:

1. Severe headache: The most common symptom, present in approximately 90% of adult patients with bacterial meningitis; typically the earliest presenting complaint.
2. Neck stiffness (nuchal rigidity): The inability to passively flex the neck forward due to severe muscle rigidity; present in approximately 70% of adult cases.
3. Altered mental status: Including confusion, drowsiness, or reduced level of consciousness.

All three symptoms of the classic triad are present simultaneously in only 40 to 50% of all cases of bacterial meningitis. However, if none of the three signs are present, meningitis is considered extremely unlikely.

Incubation Period

The incubation period varies depending on the causative organism:

• Viral meningitis: 3 to 6 days
• Bacterial meningitis: 3 to 10 days

Important: The disease is contagious only during the acute phase, which is the period when symptoms are actively present.

Early Warning Signs

Research has identified a set of early symptoms that may appear in the first hours of meningococcal disease. These symptoms often occur before the classic triad becomes evident. These early signs typically manifest within the first 8 hours of illness (Thompson M et al., The Lancet 2006):

• Leg pain: Severe, unusual limb pain that is disproportionate to any apparent cause.
• Cold hands and feet: Despite fever elsewhere in the body.
• Abnormal skin color: Pallor, grey, or blue-tinged coloration (cyanosis) around the lips.

These early signs are critical to recognize because the more commonly known symptoms typically appear much later. They usually develop between 13 and 22 hours after initial infection.

Full Symptom Description

Symptoms of meningitis vary by patient age and causative organism. Since both bacterial and viral forms can initially cause similar flu-like symptoms, and bacterial meningitis can worsen rapidly, rapid diagnosis is essential.

Onset may be sudden or may follow several days of prodromal symptoms such as cold symptoms, runny nose, diarrhea, or vomiting.

Common and characteristic symptoms include:

• Fever and chills
• Tachypnea (abnormally rapid breathing)
• Excessive drowsiness and lethargy (reduced level of consciousness)
• Irritability
• Severe headache
• Photophobia (sensitivity of the eyes to light)
• Neck stiffness (torticollis)
• Muscle pain and joint pain
• Skin rash (see below)
• Seizures (convulsions)

Symptoms in Newborns and Infants

Neonates and young infants may not display the classic triad and instead may present with:

• Jaundice (yellowing of the skin)
• Body and neck rigidity
• Fever, or paradoxically a below-normal temperature
• Poor appetite / feeding difficulties
• Weak or reluctant feeding
• A high-pitched, unusual cry
• Bulging fontanelle: A bulge in the soft spot on the top of the baby’s skull, indicating increased intracranial pressure

Infants who are unusually difficult to comfort, even when held and rocked, may be showing early signs of meningitis. They should be evaluated by a physician without delay.

Skin Rash

A skin rash is a characteristic feature of meningococcal disease, though it is not universally present. When present, it appears as:

• Red or purple spots or patches that initially may be small and sparse, potentially appearing anywhere on the body.
• The spots may rapidly enlarge into more extensive patches resembling bruises or petechiae.
• Crucially: The rash does not fade when pressed, such as when a glass tumbler is pressed against it. This non-blanching characteristic distinguishes it from many other rashes.

The non-blanching rash is a sign of septicemia (sepsis) and constitutes a medical emergency requiring immediate intervention.

Fulminant Meningitis

Fulminant meningitis is a rare but potentially fatal form of the disease characterized by an exceptionally rapid and aggressive clinical course.

While most cases begin with 3 to 5 days of non-specific but progressively worsening symptoms (malaise, fever, irritability, vomiting), fulminant forms can deteriorate with terrifying speed. As the MSD Manuals describe it, bacterial meningitis is one of the few conditions in which a previously healthy young person can go to sleep with mild symptoms and not wake up.

Tragically, the initial symptoms of fulminant meningitis are often indistinguishable from milder forms, making early diagnosis and prediction of severe complications virtually impossible in many cases. The most feared complication is cerebral edema, or brain swelling. This is the most common cause of death in acute and fulminant meningitis and is often refractory to treatment.

---

When to Call a Doctor

Meningitis can kill within hours. Seek emergency medical attention immediately if any of the following symptoms appear, especially in combination:

• Vomiting
• Severe headache
• Lethargy or abnormal drowsiness
• Confusion or altered mental status
• Stiff neck
• Skin rash (particularly non-blanching spots)
• High fever

For infants: Any baby with fever, unusual irritability, lethargy, or feeding difficulties should be seen by a doctor as soon as possible. Do not wait.

If you have been in contact with a confirmed case of meningitis: Contact your doctor promptly to determine whether preventive antibiotic prophylaxis is recommended for you and others in your household.

---

Contagion

How Does Meningitis Spread?

Most cases of meningitis, whether viral or bacterial, stem from contagious infections. These are spread through tiny respiratory droplets, which are expelled from the nose and throat of an infected person. These droplets are released when the person:

• Coughs
• Sneezes
• Talks
• Laughs

Others become infected by inhaling these droplets or by touching contaminated surfaces and then touching their nose or mouth.

Transmission also occurs through direct sharing of food, drinks, utensils, tissues, or towels with an infected person. Some pathogens can spread through the fecal-oral route, so thorough handwashing after bathroom use is critically important.

In most cases, transmission requires prolonged close contact, such as living in the same household or intimate contact (kissing, sharing eating utensils). Casual contact, such as briefly being near an infected person at school or work, is generally not enough to transmit the causative organisms.

Bacterial Meningitis

Neisseria meningitidis (meningococcus): This bacterium commonly and harmlessly colonizes the nose and throat of approximately 1 in 4 people who are asymptomatic carriers. Because it cannot survive outside the human body, transmission requires close personal contact (intimate kissing, coughing, sneezing). Only rarely does the bacterium overcome immune defenses to enter the bloodstream and reach the meninges. This is why most carriers never develop the disease.

The vast majority of meningococcal infections are isolated cases. Small clusters in families or communities occur only occasionally.

Streptococcus pneumoniae (pneumococcus): A less common but important cause of bacterial meningitis. Like meningococcus, pneumococcus habitually colonizes the respiratory mucosa of many healthy individuals without causing harm. Notably, pneumococcal meningitis is generally considered non-contagious from person to person in the same way as meningococcal disease.

Viral Meningitis

Close contact with a person who has viral meningitis may result in transmission of the virus itself, but it is relatively unlikely that the virus will reach the meninges in the exposed person. More commonly, the contact will either remain uninfected or develop a different manifestation of the same viral infection. For example, they might experience gastrointestinal symptoms (enterovirus), chickenpox (varicella-zoster), or mumps (paramyxovirus).

---

Risks and Complications

Meningitis, especially bacterial meningitis, can lead to serious and permanent complications. This is true even for patients who survive and receive treatment promptly. Common long-term sequelae include:

Neurological complications:

• Hearing loss (deafness): One of the most frequent complications; audiological testing is routinely recommended following discharge.
• Visual impairment or blindness
• Seizure disorders (epilepsy)
• Intellectual disabilities or learning difficulties
• Memory and concentration problems
• Balance and coordination difficulties

Systemic complications:

• Septicemia: Bacterial spread to the bloodstream can cause disseminated intravascular coagulation (DIC) and multiorgan failure.
• Limb amputation: Severe meningococcal septicemia can cause tissue necrosis requiring amputation of fingers, toes, or limbs.
• Cardiac, renal, and adrenal gland damage

Some children develop lifelong neurological problems. However, with prompt diagnosis and treatment, the majority of patients recover fully. Fatalities occur in a small but significant minority of cases, most frequently affecting newborns and elderly individuals.

---

Diagnosis

Clinical Assessment and First-Line Tests

Meningitis diagnosis is a medical emergency: time is an absolutely critical factor in improving outcomes. Every minute of delay in diagnosis and treatment worsens prognosis.

The diagnostic workup begins with:

1. Thorough physical and neurological examination: The physician looks for signs of meningeal irritation, particularly the following:

   • Nuchal rigidity (inability to flex the chin toward the chest)
   • Kernig’s sign (inability to extend the knee when the hip is flexed at 90°)
   • Brudzinski’s sign (involuntary flexion of the knees when the neck is passively flexed)
   • Non-blanching petechial or purpuric rash (a sign of septicemia)

2. Urgent blood tests:

   • C-reactive protein (CRP) and procalcitonin: Inflammatory biomarkers elevated in bacterial infection
   • Full blood count: Leukocytosis (elevated white blood cells) with neutrophilia in bacterial meningitis
   • Coagulation studies: To detect early disseminated intravascular coagulation (DIC)
   • Blood cultures: Critical for identifying the causative bacterium and guiding antibiotic selection

Lumbar Puncture (Spinal Tap)

The cornerstone diagnostic procedure for meningitis is the lumbar puncture (also called a spinal tap or rachicentesis). This procedure involves inserting a thin needle between two lumbar vertebrae to collect a small sample of cerebrospinal fluid (CSF) from the spinal canal.

Analysis of the CSF allows clinicians to:

• Immediately distinguish between bacterial meningitis and viral meningitis. Bacterial meningitis typically presents with turbid or cloudy CSF, low glucose, high protein, and a high white blood cell count, predominantly neutrophils. In contrast, viral meningitis usually involves clear CSF with near-normal glucose and modestly elevated lymphocytes and protein.
• Identify the specific causative organism through:
  • CSF culture (gold standard, though results take 24–72 hours)
  • PCR (polymerase chain reaction): Rapid molecular testing that can identify bacterial and viral DNA within hours, even after antibiotic treatment has begun

Imaging and Monitoring

In certain patients, especially those showing signs of elevated intracranial pressure, focal neurological deficits, or altered consciousness, the physician may order a CT scan or MRI of the brain before proceeding with a lumbar puncture. These imaging studies help to:

• Exclude conditions that might make lumbar puncture unsafe (e.g., cerebral herniation risk due to severe brain swelling or a space-occupying lesion)
• Identify complications such as brain abscesses, subdural empyema, or cerebral venous thrombosis

Important: The administration of antibiotics should never be delayed while waiting for imaging results in suspected bacterial meningitis. If imaging is required before lumbar puncture, empirical antibiotic therapy must be started immediately.

---

Treatment

Goals and Therapeutic Approaches

The primary goals of meningitis treatment are to:

1. Eliminate the causative pathogen
2. Reduce inflammation of the meningeal membranes
3. Prevent permanent neurological damage
4. Manage complications and support vital functions

The specific approach varies fundamentally depending on whether the cause is bacterial, viral, or fungal. In virtually all cases, treatment requires hospital admission with close clinical monitoring. For severe cases, this often takes place in an intensive care unit (ICU).

Treatment of Bacterial Meningitis

Bacterial meningitis is a critical emergency requiring:

Immediate Intravenous Antibiotics

Empirical (broad-spectrum) antibiotic therapy must be initiated immediately, as waiting for culture results can significantly worsen outcomes. Every minute of delay has a major impact on patient prognosis. Common empirical regimens include:

• Third-generation cephalosporins (e.g., ceftriaxone or cefotaxime): The backbone of treatment for most cases in children and adults
• Ampicillin: Added for neonates and elderly patients to cover Listeria monocytogenes
• Vancomycin: Added in settings with high rates of penicillin-resistant pneumococci

Once CSF culture and sensitivity results are available, antibiotic therapy is tailored to the specific organism identified.

Corticosteroids (Dexamethasone)

Current international guidelines recommend early adjunctive corticosteroid therapy (intravenous dexamethasone), ideally administered before or with the first dose of antibiotics. Evidence shows that dexamethasone:

• Reduces cerebral edema and inflammation
• Significantly decreases the risk of hearing loss and other neurological sequelae
• Improves overall outcomes, particularly in pneumococcal meningitis

Treatment of Viral and Fungal Meningitis

Viral Meningitis

Most cases of viral meningitis are self-limiting and resolve without specific antiviral therapy. Management is primarily supportive:

• Complete rest
• Adequate hydration (oral or intravenous)
• Analgesics and antipyretics for headache and fever management (e.g., paracetamol, ibuprofen)

Exception: Meningitis caused by herpes simplex virus (HSV) or varicella-zoster virus requires prompt treatment with intravenous acyclovir, as these viral infections can cause severe and potentially fatal encephalitis if left untreated.

Fungal Meningitis

Fungal meningitis, most often caused by Cryptococcus neoformans in immunocompromised patients such as those with HIV/AIDS, requires prolonged antifungal therapy. This treatment usually involves a combination of medications.

• Amphotericin B (intravenous, induction phase)
• Flucytosine (in combination)
• Followed by oral fluconazole for consolidation and maintenance

Treatment courses may extend for weeks to months, requiring close monitoring for drug toxicity.

Intensive Support and Complication Management

In severe or critical cases, additional interventions may be required to stabilize vital functions:

• Respiratory support: Supplemental oxygen or mechanical ventilation for patients with respiratory compromise or reduced consciousness
• Anticonvulsant medications: To prevent or treat seizures (e.g., benzodiazepines acutely; levetiracetam or phenytoin for ongoing seizure control)
• Hemodynamic management: Intravenous fluid resuscitation and vasopressors for septic shock
• Intracranial pressure monitoring and management: Elevation of the head of the bed, osmotic therapy (mannitol or hypertonic saline) for cerebral edema
• Monitoring of electrolytes: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common complication requiring careful fluid management

Recovery and Lifestyle

Recovery does not end at hospital discharge. A period of gradual convalescence is essential:

• Avoid physical exertion and excessive stress during the first weeks after discharge
• Follow-up audiological and neurological assessments are strongly recommended, as meningitis may leave subtle long-term effects (concentration difficulties, chronic fatigue, mild hearing loss)
• Balanced nutrition and adequate sleep support immune system recovery
• Psychological support: Some survivors experience anxiety, depression, or post-traumatic stress related to their illness. These issues should be addressed proactively

---

Vaccine and Prevention

Vaccination remains the most powerful tool for preventing meningitis. Available vaccines can protect against the most dangerous causative organisms:

Vaccines That Protect Against Meningitis

Important caveat: Even receiving all currently available meningitis vaccines does not confer complete immunity against all forms of meningitis, as vaccines do not exist for every causative organism. Discussing the appropriate vaccination schedule with your doctor or pediatrician, which should include an individualized risk-benefit assessment, is always recommended.

Who Should Be Vaccinated?

• Children: Childhood vaccination schedules include meningococcal, pneumococcal, and Hib vaccines as standard components in most countries.
• Adolescents (11–18 years): Strongly recommended to receive meningococcal vaccination (MenACWY and MenB), especially those entering communal living environments (dormitories, boarding schools, summer camps).
• Adults with risk factors: Including travelers to high-risk regions, individuals with certain medical conditions (such as asplenia, complement deficiencies, diabetes, severe liver disease, or immunodeficiencies, which include HIV/AIDS), and healthcare workers.

General Hygiene Measures

Beyond vaccination, the following measures help reduce the risk of meningitis transmission:

• Frequent and thorough handwashing: Particularly before meals and after using the toilet.
• Avoid sharing personal items: Do not share food, drinks, eating utensils, toothbrushes, cigarettes, or lip balm with others.
• Avoid close contact with known cases: If you have been in close contact with a confirmed meningitis case, seek medical advice promptly regarding antibiotic prophylaxis.
• Reduce overcrowding and promiscuous social behaviors: Particularly among adolescents and young adults in communal settings.
• Regular cleaning and disinfection: Floors, washable surfaces, and shared items (especially in nurseries, kindergartens, and schools) should be cleaned regularly with standard household detergents.
• Avoid soft, non-washable toys in nurseries and childcare settings.

Antibiotic Prophylaxis for Close Contacts

For certain bacterial forms (particularly meningococcal disease), individuals who have had close contact with a confirmed case are at significantly elevated risk. In these situations, preventive antibiotic treatment (prophylaxis), typically involving rifampicin, ciprofloxacin, or ceftriaxone, is strongly recommended. It should be initiated as soon as possible after exposure.

---

Sources and Bibliography

• Italian National Institute of Health (ISS) – Meningitis (Epicentro)
• AIFA – Meningitis Patient Information Leaflet (ISS Vademecum)
• Centers for Disease Control and Prevention (CDC) – Meningitis
• NHS – Meningitis
• Attia J et al. – The Rational Clinical Examination: Does this adult patient have acute meningitis? – JAMA, PubMed
• Thompson M, Ninis N, Perera R et al. – Clinical recognition of meningococcal disease in children and adolescents – The Lancet 2006
• Durand ML et al. – Acute bacterial meningitis in adults – NEJM, PubMed
• MSD Manuals – Acute Bacterial Meningitis (Professional)